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Background
The differential diagnosis between bacterial and viral
meningitis is based on the cerebrospinal fluid (CSF) cellu-
lar and biochemistries characteristics, it is important for
the adequate treatment and prognosis. CSF lactic acid
determination is considered the best biomarker for this
differential diagnosis. The objectives of this study were to
quantify CSF lactic acid levels in bacterial and viral men-
ingitis comparing with other infectious and noninfectious
central nervous system diseases; and to calculate the CSF
acid lactic operational characteristics as a biomarker for
the differential diagnosis between bacterial and viral men-
ingitis.
Materials and methods
It was studied prospectively 139 CSF samples, collected by
lumbar puncture. The samples were distributed in the
groups: Group 1 (n 33) CSF with viral meningitis charac-
teristics; Group 2 (n 8) suspicion of viral meningitis
although CSF had predominance of neutrofils; Group 3
(n 20) bacterial meningitis; Group 4 (n 17) neurological
diseases; Group 5 (n 42) normal CSF; Group 6 (n 15)
traumatic lumbar puncture; Group 7 (n 4) chronic men-
ingitis (mycobacterium tuberculosis, cryptococos neofor-
mans, candida sp). The levels of CSF lactic were
determined by the AIR DIMENSION equipment (Dade
Behring).
Results
CSF lactic acid concentration was more elevated in the
group with bacterial meningitis (8.7 ± 5.4 mmol/L) than
in the groups with viral meningitis, normal CSF, nonin-
fectious CNS diseases and chronic meningitis (1.9 ± 0.6;
1.8 ± 0.6; 3.1 ± 3.7; 5.5 ± 2.8 mmol/L respectively) P ≤
0.0001. The CSF acid lactic concentration in the group
with viral meningitis and CSF neutrofils predominance
was 2.5 ± 0.4 mmol/L. The quantification of CSF lactic
acid to discriminate bacterial from viral, meningitis with
the cut-off of 3.5 mmol/L, had a sensibility of 80%, spe-
cificity of 97%, positive predictive value of 94% and neg-
ative predictive value of 89%.
Conclusion
CSF lactic acid levels were four times higher in the bacte-
rial meningitis group than in the viral meningitis group.
In the CSF samples with suspicion of viral meningitis with
predominance of neutrofils and normal glucose the CSF
lactic acid levels were similar to the levels in the CSF sam-
ples with viral meningitis but lower than in the samples
with bacterial meningitis. The CSF lactic acid to discrimi-
nate bacterial meningitis from viral meningitis has high
sensibility, specificity and predictive values.
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